Bioorthogonal Prodrug–Antibody Conjugates for On-Target and On-Demand Chemotherapy

Authors:

Abstract
Current antibody–drug conjugates (ADCs) suffer from low tissue penetration and significant side effects, largely due to the permanent linkage and/or premature release of cytotoxic payloads. Herein,...

This publication has 42 references indexed in Scilit: